Protein carbonyls in the lung parenchyma of patients with COPD

T. Hackett, J. Warner (Southampton, United Kingdom)

Source: Annual Congress 2010 - Novel mechanisms in COPD
Session: Novel mechanisms in COPD
Session type: Thematic Poster Session
Number: 4343
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Hackett, J. Warner (Southampton, United Kingdom). Protein carbonyls in the lung parenchyma of patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 4343

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Protein oxidation in the diaphragm of patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 358s
Year: 2003

Morphology of pulmonary tissue in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 456s
Year: 2003

Cytokine profiles in the lungs of patients with interstitial and obstructive lung diseases
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018

Surfactant protein-A in lung tissue obtained from patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006

Lung compliance in patients with pulmonary fibrosis with normal lung volumes
Source: Eur Respir J 2007; 30: Suppl. 51, 577s
Year: 2007

Reduction of denitration-like activity in COPD lung tissue
Source: Eur Respir J 2004; 24: Suppl. 48, 99s
Year: 2004

Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001

Lung and serum biomarkers of tissue lesions due to acute exacerbation of COPD
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012

Deposition of aerosols in the lung periphery of patients with lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 212s
Year: 2001

Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Characterization of lung volumes in COPD
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Pecularities of lung cancer in patients with COPD
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011


Expression of versican in large and small airways and parenchyma in lungs of non-smokers, smokers and COPD patients
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009


Carbonylated proteins in BAL of patients with interstititial lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 344s
Year: 2005

Expansion of alveolar-lymphoid interfaces in lungs of patients with COPD
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012

Lung cancer in COPD patients
Source: Annual Congress 2009 - The lung cancer-COPD nexus
Year: 2009


Is lung emphysema in COPD patients reflected by central airways inflammation?
Source: Eur Respir J 2003; 22: Suppl. 45, 207s
Year: 2003

Analysis of antioxidant proteins and oxidized proteins in BAL of patients with interstitial lung diseases
Source: Eur Respir J 2004; 24: Suppl. 48, 42s
Year: 2004

Lipid metabolite levels recovered from BAL fluid correlate with lung function of COPD patients and controls
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008


Airways and systemic inflammation and correlation to lung function in smokers and in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 651s
Year: 2006